Aptus Capital Advisors LLC Trims Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Aptus Capital Advisors LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 466 shares of the exchange traded fund’s stock after selling 235 shares during the period. Aptus Capital Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $42,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in XBI. Wealth Enhancement Advisory Services LLC grew its position in SPDR S&P Biotech ETF by 1.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 120,504 shares of the exchange traded fund’s stock worth $11,906,000 after buying an additional 1,941 shares in the last quarter. ST Germain D J Co. Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $108,000. Fulcrum Capital LLC increased its position in shares of SPDR S&P Biotech ETF by 3.1% in the fourth quarter. Fulcrum Capital LLC now owns 49,666 shares of the exchange traded fund’s stock worth $4,473,000 after purchasing an additional 1,470 shares during the last quarter. Global Financial Private Client LLC increased its position in shares of SPDR S&P Biotech ETF by 8.5% in the fourth quarter. Global Financial Private Client LLC now owns 9,326 shares of the exchange traded fund’s stock worth $840,000 after purchasing an additional 727 shares during the last quarter. Finally, Fortis Advisors LLC raised its stake in SPDR S&P Biotech ETF by 12.3% in the fourth quarter. Fortis Advisors LLC now owns 5,950 shares of the exchange traded fund’s stock valued at $536,000 after purchasing an additional 650 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $76.39 on Friday. The firm has a 50 day simple moving average of $80.77 and a two-hundred day simple moving average of $89.22. The stock has a market cap of $4.85 billion, a PE ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.